Summary
RPG Life Sciences has invested ₹215 crore in two acquisitions within five weeks, aiming for significant API expansion and plans to deploy an additional ₹500-700 crore over the next year while expanding its API workforce.
RPG Life Sciences Invests ₹215 Crore in Acquisitions for Major API Expansion
HyperFast News
Related news
RPG Life Sciences Plans Bigger API Push After ₹215 Cr Acquisitions, Expands Capacity Fivefold
14 Sept 2026, 2:59 pm · News
RPG Life Sciences to Launch GLP-1 Drug in October After ₹215 Crore API Acquisitions
14 Sept 2026, 2:59 pm · News
RPG Life Sciences invests in API business, eyes 'China-plus one' advantage
14 Sept 2026, 2:59 pm · News
